<table width="90%" xmlns="urn:hl7-org:v3" xmlns:voc="urn:hl7-org:v3/voc" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<caption>Table 4 Clarithromycin Susceptibility Test Results and Clinical/Bacteriological Outcomes</caption>
<colgroup>
<col align="left" width="25%"></col>
<col align="center" width="15%"></col>
<col align="center" width="15%"></col>
<col align="center" width="10%"></col>
<col align="center" width="10%"></col>
<col align="center" width="10%"></col>
<col align="center" width="5%"></col>
</colgroup>
<thead>
<tr>
<th align="center" colspan="6">Clarithromycin Susceptibility Test Results and Clinical/Bacteriological Outcomes
                                                <footnote>Includes only patients with pretreatment clarithromycin susceptibility test results</footnote>
</th>
</tr>
<tr>
<th align="center" colspan="2">Clarithromycin Pretreatment Results</th>
<th align="center" colspan="5">Clarithromycin Post-treatment Results</th>
</tr>
<tr>
<th></th>
<th></th>
<th valign="top">negative – eradicated
                                                <content stylecode="italics">H. pylori</content>
</th>
<th colspan="4" valign="top">positive – not eradicated Post-treatment susceptibility results
                                                <content stylecode="italics">H. pylori</content>
<br/>
</th>
</tr>
<tr>
<th></th>
<th></th>
<th></th>
<th>S
                                                <footnote id="table4a">Susceptible (S) MIC ≤ 0.25 mcg/mL, Intermediate (I) MIC 0.5 to 1.0 mcg/mL, Resistant (R) MIC ≥ 2 mcg/mL</footnote>
</th>
<th>I</th>
<th>R</th>
<th>No MIC</th>
</tr>
</thead>
<tbody>
<tr>
<td colspan="6">Dual Therapy – (omeprazole 40 mg once daily/clarithromycin 500 three times daily for 14 days followed by omeprazole 20 mg once daily for another 14 days) (Studies 4, 5)</td>
</tr>
<tr>
<td>Susceptible</td>
<td>108</td>
<td>72</td>
<td>1</td>
<td></td>
<td>26</td>
<td>9</td>
</tr>
<tr>
<td>Intermediate</td>
<td>1</td>
<td></td>
<td></td>
<td></td>
<td>1</td>
<td></td>
</tr>
<tr>
<td>Resistant</td>
<td>4</td>
<td></td>
<td></td>
<td></td>
<td>4</td>
<td></td>
</tr>
<tr>
<td colspan="6">Triple Therapy – (omeprazole 20 mg twice daily/clarithromycin 500 mg twice daily/amoxicillin 1 g twice daily for 10 days – Studies 1, 2, 3; followed by omeprazole 20 mg once daily for another 18 days – Studies 1, 2)</td>
</tr>
<tr>
<td>Susceptible</td>
<td>171</td>
<td>153</td>
<td>7</td>
<td></td>
<td>3</td>
<td>8</td>
</tr>
<tr>
<td>Intermediate</td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
<td></td>
</tr>
<tr>
<td>Resistant</td>
<td>14</td>
<td>4</td>
<td>1</td>
<td></td>
<td>6</td>
<td>3</td>
</tr>
</tbody>
</table>